PHARMACOKINETICS OF WEEKLY LOW-DOSE DOXORUBICIN

被引：15

作者：

FRENAY, M ^{[1
]}

MILANO, G ^{[1
]}

RENEE, N ^{[1
]}

PONS, D ^{[1
]}

KHATER, R ^{[1
]}

FRANCOIS, E ^{[1
]}

THYSS, A ^{[1
]}

NAMER, M ^{[1
]}

机构：

[1] CTR ANTOINE LACASSAGNE,36 VOIE ROMAINE,F-06054 NICE,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 02期

关键词：

D O I：

10.1016/0277-5379(89)90007-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：191 / 195

页数：5

共 21 条

[1]

BENJAMIN RS, 1977, CANCER RES, V37, P1416

[2]

BOSTON RC, 1983, CANCER TREAT REP, V67, P63

[3]

CHLEBOWSKI RT, 1980, CANCER TREAT REP, V64, P47

[4] DEPENDENCE OF THE CYTOSTATIC EFFECT OF ADRIAMYCIN ON DRUG CONCENTRATION AND EXPOSURE TIME INVITRO [J].

EICHHOLTZWIRTH, H .

BRITISH JOURNAL OF CANCER, 1980, 41 (06) :886-891

[5] PHARMACOKINETIC STUDY OF IV-INFUSIONS OF ADRIAMYCIN [J].

EKSBORG, S ;

STRANDLER, HS ;

EDSMYR, F ;

NASLUND, I ;

TAHVANAINEN, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (02) :205-212

[6]

GREENE RF, 1983, CANCER RES, V43, P3417

[7] WEEKLY ADRIAMYCIN VERSUS VAC IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL [J].

GUNDERSEN, S ;

KVINNSLAND, S ;

KLEPP, O ;

KVALOY, S ;

LUND, E ;

HOST, H .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (12) :1431-1434

[8]

HASKELL CM, 1974, CANCER RES, V34, P2991

[9]

JONES WG, 1984, CANCER TREAT REP, V68, P675

[10] HOW MUCH DOES LIVER-DISEASE AFFECT THE PHARMACOKINETICS OF ADRIAMYCIN [J].

KAYE, SB ;

CUMMINGS, J ;

KERR, DJ .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08) :893-895

← 1 2 3 →